BAMCO Inc Portfolio holdings
AUM
$36.9B
1-Year Return
31.2%
This Quarter Return
-13.95%
1 Year Return
+31.2%
3 Year Return
+112.46%
5 Year Return
+202.3%
10 Year Return
+748.08%
AUM
$20.4B
AUM Growth
-$5.78B
(-22%)
Cap. Flow
-$647M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
372
New
19
Increased
153
Reduced
118
Closed
35
Top Buys
| 1 |
GDS Holdings
GDS
|
$46.2M |
| 2 |
Vertiv
VRT
|
$43.3M |
| 3 |
Schrodinger
SDGR
|
$41M |
| 4 |
Afya
AFYA
|
$35.4M |
| 5 |
MSCI
MSCI
|
$29.8M |
Top Sells
| 1 |
Petrobras
PBR
|
$129M |
| 2 |
CoStar Group
CSGP
|
$101M |
| 3 |
IAC Inc
IAC
|
$75.9M |
| 4 |
TIF
Tiffany & Co.
TIF
|
$65.1M |
| 5 |
MOMO
Hello Group
MOMO
|
$58.4M |
Sector Composition
| 1 | Technology | 21.3% |
| 2 | Financials | 18.07% |
| 3 | Consumer Discretionary | 17.8% |
| 4 | Healthcare | 15.42% |
| 5 | Real Estate | 12.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNFT
276
DELISTED
Benefitfocus, Inc.
BNFT
| $931K | ﹤0.01% |
104,488
-3,629,619
| -97% | -$32.3M |
|
277
Abbott
ABT
$231B
| $882K | ﹤0.01% |
11,171
+1,575
| +16% | +$124K |
|
278
Thermo Fisher Scientific
TMO
$185B
| $845K | ﹤0.01% |
2,980
+299
| +11% | +$84.8K |
|
279
Novanta
NOVT
$4.15B
| $833K | ﹤0.01% |
10,431
| – | – |
|
|
OPRA
280
Opera Ltd
OPRA
$1.59B
| $799K | ﹤0.01% |
148,784
-118,317
| -44% | -$635K |
|
281
Wingstop
WING
$8.62B
| $797K | ﹤0.01% |
10,000
-40,000
| -80% | -$3.19M |
|
282
Limoneira
LMNR
$288M
| $742K | ﹤0.01% |
56,609
-233,391
| -80% | -$3.06M |
|
283
Moody's
MCO
$89.6B
| $714K | ﹤0.01% |
3,378
+1,723
| +104% | +$364K |
|
284
Travel + Leisure Co
TNL
$4.12B
| $694K | ﹤0.01% |
32,000
| – | – |
|
285
Lindblad Expeditions
LIND
$793M
| $592K | ﹤0.01% |
142,000
+62,600
| +79% | +$261K |
|
|
INFO
286
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $558K | ﹤0.01% |
9,302
+4,100
| +79% | +$246K |
|
287
Accenture
ACN
$158B
| $513K | ﹤0.01% |
3,141
+1,191
| +61% | +$195K |
|
288
Humana
HUM
$37.5B
| $457K | ﹤0.01% |
1,455
+105
| +8% | +$33K |
|
289
IQVIA
IQV
$31.3B
| $413K | ﹤0.01% |
3,832
+290
| +8% | +$31.3K |
|
|
TIF
290
DELISTED
Tiffany & Co.
TIF
| $388K | ﹤0.01% |
3,000
-503,568
| -99% | -$65.1M |
|
291
Danaher
DHR
$143B
| $335K | ﹤0.01% |
2,729
+254
| +10% | +$31.2K |
|
292
Berkshire Hathaway Class A
BRK.A
$1.09T
| $272K | ﹤0.01% |
1
| – | – |
|
293
Qualcomm
QCOM
$172B
| $271K | ﹤0.01% |
4,000
| – | – |
|
294
Insulet
PODD
$24.4B
| $246K | ﹤0.01% |
1,485
-200
| -12% | -$33.1K |
|
295
Global Payments
GPN
$21.2B
| $245K | ﹤0.01% |
+1,700
| New | +$245K |
|
296
Sanofi
SNY
$111B
| $222K | ﹤0.01% |
+5,080
| New | +$222K |
|
297
Zoetis
ZTS
$67.9B
| $215K | ﹤0.01% |
1,828
+628
| +52% | +$73.9K |
|
298
Procter & Gamble
PG
$373B
| $198K | ﹤0.01% |
1,796
| – | – |
|
299
Constellation Brands
STZ
$25.7B
| $197K | ﹤0.01% |
1,374
-74
| -5% | -$10.6K |
|
300
HCA Healthcare
HCA
$96.3B
| $187K | ﹤0.01% |
2,085
| – | – |
|